Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magnus Andersson

Showing results (321-330 of 324) with videos related to

Pageof 33
Sort By:
You have reached the last page of results.This site can display upto 324 results.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 2026
Quantitative assessment of flow between cerebrospinal and interstitial fluid compartments in humansAnders Wåhlin, Sofia Behndig, Johan Eriksson De Ryst, et al.
Allergy|September 13, 2019
Pollen exposure weakens innate defense against respiratory virusesStefanie Gilles, Cornelia Blume, Maria Wimmer, et al.
Genome Medicine|December 13, 2022
Loss of Y in leukocytes as a risk factor for critical COVID-19 in menBożena Bruhn-Olszewska, Hanna Davies, Daniil Sarkisyan, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 14, 2006
Pharmacological and behavioral profile of N-(4-fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl) carbamide (2R,3R)-dihydroxybutanedioate (2:1) (ACP-103), a novel 5-hydroxytryptamine(2A) receptor inverse agonistKimberly E Vanover, David M Weiner, Malath Makhay, et al.
Pageof 33

Showing results (321-330 of 324) with videos related to

Sort By:
Pageof 33
You have reached the last page of results.This site can display upto 324 results.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 2026
Quantitative assessment of flow between cerebrospinal and interstitial fluid compartments in humansAnders Wåhlin, Sofia Behndig, Johan Eriksson De Ryst, et al.
Allergy|September 13, 2019
Pollen exposure weakens innate defense against respiratory virusesStefanie Gilles, Cornelia Blume, Maria Wimmer, et al.
Genome Medicine|December 13, 2022
Loss of Y in leukocytes as a risk factor for critical COVID-19 in menBożena Bruhn-Olszewska, Hanna Davies, Daniil Sarkisyan, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 14, 2006
Pharmacological and behavioral profile of N-(4-fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl) carbamide (2R,3R)-dihydroxybutanedioate (2:1) (ACP-103), a novel 5-hydroxytryptamine(2A) receptor inverse agonistKimberly E Vanover, David M Weiner, Malath Makhay, et al.
Pageof 33